The effects of restraint stress on the neuropathogenesis of theiler's virus-induced demyelination: A murine model for multiple sclerosis

Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity

Volumn , Issue , 2006, Pages 190-215

  Welsh, C Jane ^a   Wentao, Mi ^a   Sieve, Amy ^b   Steelman, Andrew ^a   Johnson, Robin R ^c   Young, Colin R ^a   Prentice, Thomas ^c   Hammons, Ashley ^a   Storts, Ralph ^a   Welsh, Thomas ^c   Meagher, Mary W ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250711361     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48334-4_10     Document Type: Chapter

References (121)

1. Acheson, E. D. (1977). Epidemiology of multiple sclerosis. Br. Med. Bull. 33:9-14.
2. Ackerman, K. D., Martino, M., Heyman, R., Moyna, N. M., and Rabin, B. S. (1996). Immunologic response to acute psychological stress in MS patients and controls. J. Neuroimmunol. 68(1-2):85-94.
3. Ackerman, K. D., Stover, A., Heyman, R., Anderson, B. P., Houck, P. R., Frank, E., Rabin B. S., and Baum, A. (2003). Robert Ader New Investigator award. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav. Immun. 17:141-151.
4. Ader, R., Felten, D. L., and Cohen, N. (1991). Psychoneuroimmunology. New York: Academic Press.
5. Allen, I., and Brankin, B. J. (1993). Pathogenesis of multiple sclerosis-the immune diathesis and the role of viruses. Neuropathol. Exp. Neurol. 52:95.
6. Aubert, C., Chamorro, M., and Brahic, M. (1987). Identification of Theiler's infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathogen. 3:319-326.
7. b gene become resistant to persistent infection by Theiler's virus. J. Virol. 68:4049-4052.
8. Anderson, D. W., Ellenberg, J. H., Leventhal, C. M., Reingold, S. C., Rodriguez, M., and Silberberg, D. H. (1992). Revised estimate of the prevalence of multiple sclerosis in the United States. Ann. Neurol. 31:333-336.
9. Begolka, W. S., Vanderlugt, C. L., Rahbe, S. H., and Miller, S. D. (1998). Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161:4437-4446.
10. Blakemore, W. F., Welsh, C. J. R., Tonks, P., and Nash, A. A. (1988). Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta. Neuropath. 76:581-589.
11. Borrow, P., and Nash, A. A. (1992). Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunol. 76:133-139.
12. Borrow, P., Tonks, P., Welsh, C. J. R., and Nash, A. A. (1992). The role of CD8+ T cells in the acute and chronic phases of Theiler's virus-induced disease in mice. J. Gen. Virol. 73:1861-1865.
13. Borrow, P., Welsh, C. J. R., and Nash, A. A. (1993). Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis. Immunology 80:502-506.
14. Borrow, P., Welsh, C. J. R., Dean, D., Tonks, P., Blakemore, W. F., and Nash, A. A. (1998). Investigation of the role of autoimmune responses to myelin in the pathogenesis of TMEV-induced demyelinating disease. Immunology 93:478-484.
15. Bradley, L. A., Young, L. D., Anderson, K. O., Turner, R. A., Agudelo, C. A., McDaniel, L. K., Pisko, E. J., Semble, E. L., and Morgan, T. M. (1987). Effects of psychological therapy on pain behavior of rheumatoid arthritis patients: Treatment outcome and six-month follow-up. Arthritis Rheum. 30:1105-1114.
16. Brahic, M., Stroop, W. G., and Baringer, J. R. (1981). Theiler's virus persists in glial cells during demyelinating disease. Cell 26:123-128.
17. Bright, J. J., Rodriguez, M., and Sriram, S. (1999). Differential influence of Interleukin-IL-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination. J. Virol. 73:1637-1639.
18. Bureau, J. F., Montagutelli, X., Lefebvre, S., Guenet, J. L., Pla, M., and Brahic, M. (1992). The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J. Virol. 66:4698-4704.
19. Bureau, J. F., Montagutelli, X., Bihl, F., Lefebvre, S., Guenet, J. L., and Brahic, M. (1993). Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:82-91.
20. Campbell, T., Meagher, M. W., Sieve, A., Scott, B., Storts, R., Welsh, T. H., and Welsh, C. J. R. (2001). The effects of restraint stress on the neuropathogenesis of Theiler's virus-induced demyelination. I. Acute disease. Brain Behav. Immun. 15:235-254.
21. Challoner, P. B., Smith, K. T., Parker, J. D., Macleod, D. L., Coulter, S. N., Rose, T. M., Schultz, E. R., Bennett, J. L., Garber, R. L., Chang, M., Schad, P. A., Sewart, P. M., Nowinski, R. C., Brown, J. P., and Burmer, G. C. (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92:7440-7444.
22. Chang, J. R., Zaczynaska, E., Katsetos, C. D., Platsoucas, C. D., and Oleszak, E. L. (2000). Differential expression of TGF-β, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice. Virology 278:346-360.
23. Charcot, J. M. (1877). Lectures on Diseases on the Nervous System. G. Sigerson, trans. London: New Sydenham Society.
24. Clatch, R. J., Lipton, H. L., and Miller, S. D. (1987). Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb. Pathogen. 3:327-337.
25. Clatch, R. J., Miller, S. D., Metzner, R., Dal Canto, M. C., and Lipton, H. L. (1990). Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254.
26. Dhabhar, F. S., and McEwen, B. S. (1996). Stress-induced enhancement of antigen specific cell-mediated immunity. J. Immunol. 156:2608-2615.
27. Dobbs, C. M., Vasquez, M., Glaser, R., and Sheridan, J. F. (1993). Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J. Neuroimmunol. 48:151-160.
28. Drescher, K. M., Murray, P. D., Lin, X., Carlino, J. A., and Rodriguez, M. (2000). TGF-β2 reduces demyelination, virus antigen expression and macrophage recruitment in a viral model of multiple sclerosis. J. Immunol. 164:3207-3213.
29. Dal Canto, M. C., and Rabinowitz, S. G. (1982). Experimental models of virusinduced demyelination of the central nervous system. Ann. Neurol. 11:109-127.
30. Dal Canto, M. C., Calenoff, M. A., Miller, S. D., and Vanderlugt, C. L. (2000). Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity. J. Neuroimmunol. 104:79-84.
31. Dethlefs, S., Brahic, M., and Larsson-Sciard, E. L. (1997). An early abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing for viral persistence. J. Virol. 71:8875-8878.
32. Dhabhar, F. S., and McEwen, B. S. (1996). Stress-induced enhancement of antigen specific cell-mediated immunity. J. Immunol. 156:2608-2615.
33. Dhabhar, F. S., and McEwen, B. S. (1997). Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 11:286-306.
34. Dhabhar, F. S., Miller, A. H., McEwen, B. S., and Spencer, R. L. (1995). Effects of stress on immune cell distribution: dynamics and hormonal mechanisms. J. Immuonl. 154:5511-5527.
35. Dobbs, C. M., Vasquez, M., Glaser, R., and Sheridan, J. F. (1993). Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J. Neuroimmunol. 48:151-160.
36. Dowdell, K. C., Gienapp, I. E., Stuckman, S., Wardrop, R. M., and Whitacre, C. C. (1999). Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyeltis: a critical role for the hypothalamic-pituitary-adrenal axis. J. Neuroimmunol. 100:243-251.
37. Fiette, L., Aubert, C., Brahic, M., and Ross, C. P. (1993). Theiler's virus infection of β2-microglobulin deficient mice. J. Virol. 67:589-592.
38. Fiette, L., Aubert, C., Ulrike, M., Huang, S., Aguet, M., Brahic, M., and Bureau, J. F (1995). Theiler's virus infection of 129Sv mice that lack the interferon α/β or IFN-γ receptors. J. Exp. Med. 181:2069-2076.
39. Gerety, S. J., Clatch, R. J., Lipton, H. L., Goswami, R. G., Rundell, M. K., and Miller, S. D. (1991). Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV Identification of an immunodominant T cell determinant, on the N-terminal end of the VP-2 capsid protein in susceptible SJL/J mice. J. Immunol. 146:4322-4326.
40. Gilden, D. H. (2001). Viruses and multiple sclerosis. JAMA 286:3127-3129.
41. Grant, I. (1993). Psychosomatic-somatopsychic aspects of multiple sclerosis In U. Hailbreich (ed.), Multiple Sclerosis: A Neuropsychiatric Disorder. Washington, DC: American Psychiatric Press, pp. 119-136.
42. Griffen, A., Lo, W., Wolny, A., and Whitacre, C. (1993). Suppression of experimental allergic encephalomyelitis by restraint stress: sex differences. J. Neuroimmunol. 44:103-116.
43. Hermann, G., Beck, F. M., and Sheridan, J. F (1995). Stress-induced glucocorticoid response modulates mononuclear cell trafficking during an experimental influenza viral infection. J. Neuroimmunol. 56:179-186.
44. Hickey, W. F., Ueno, K., Hiserodt, J. C., and Schmidt, R. (1992). Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism. J. Exp. Med. 176:811-817.
45. Hilakivi-Clarke, LA., Turkka, J., Lister, R. G, and Linnoila, M. (1991). Effects of early postnatal handling on brain beta-adrenoceptors and behavior in tests related to stress. Brain Res. 542:286-292.
46. Hill, K. E., Pigmans, M., Fujinami, R. S., and Rose, J. W. (1998). Gender variations in early Theiler's virus-induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J. Neuroimmunol. 85:44-51.
47. Homo-Delarche, F., Fitzpatrick, F., Christeff, N., Nunez, E. A., Bach, J. F, and Dardenne, M. (1991). Sex steroids, glucocorticoids, stress, and autoimmunity. J. Steroid Biochem. Mol. Biol. 40:619-637.
48. IFN-β Multiple Sclerosis Study Group. (1993). IFN-β1-b is effective in relapsing remitting multiple sclerosis. I. Clinical results of a multi-center, randomized, double blind, placebo controlled trial. Neurology 43:655-661.
49. Inoue, A., Koh, C. S., Yahikozawa, H., Yanagisawa, N., Yagita, H., Ishihara, Y, and Kim, B. S. (1996). The level of tumor necrosis factor-alpha producing cells in the spinal cord correlates with the degree of Theiler's murine encephalomyelitis virusinduced demyelinating disease. Int. Immunol. 8:1001-1008.
50. Inoue, A., Koh, C-S., Yamazaki, M., Yahikozawa, H., Ichikawa, M., Yagita, H., and Kim, B. S. (1998). Suppressive effect on Theiler's murine encephalomyelitis virusinduced demyelinating disease by the administration of anti-IL12 antibody. J. Immunol. 161:5586-5593.
51. Kaminsky, S. G., Nakamura, I., and Cudkowicz, G. (1987). Defective differentiation of natural killer cells in SJL mice. Role of the thymus. J. Immunol. 138:1020-1025.
52. Kappel, C. A., Melvold, R. W., and Kim, B. S. (1990). Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J. Neuroimmunol. 29:15-19.
53. Kappel, C. A., Dal Canto, M. C., Melvold, R. W., and Kim, B. S. (1991). Hierarchy of effects of the MHC and T cell receptor beta-chains in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147:4322-4326.
54. Karpus, W. J., Clatch, R. J., and Miller, S. D. (1993). Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23:46-55.
55. Karpus, W. J., Peterson, J. D., and Miller, S. D. (1994). Anergy in vivo: Down regulation of antigen specific CD4+ Th1 but not Th2 cytokine responses. Int. Immunol. 6:721-730.
56. Karpus, W. J., Pope, J. G., Peterson, J. D., Dal Canto, M. C., and Miller, S. D. (1995). Inhibition of Theiler's virus mediated demyelination by peripheral immune tolerance induction. J. Immuol. 155:947-957.
57. Keith, L. D., Winslow, J. R., and Reynolds, R. W. (1978). A general procedure for estimation of corticosteroid response in individual rats. Steriods 31:523-531.
58. Kiecolt-Glaser, J. K., and Glaser, R. (1995). Psychoneuroimmunology and health consequences: Data and shared mechanisms. Psychosom. Med. 57:269-274.
59. Kohanawa, M., Nakane, A., and Minagawa, T. (1993). Endogenous gamma interferon produced in central nervous system by systemic infection with Theiler's virus in mice. J. Neuroimmunol. 48:205-211.
60. Larsson-Sciard, E. L., Dethlefs, S., and Brahic, M. (1997). In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence. J. Virol. 71:797-799.
61. Levine, S., Strebel, R., Wenk, E., and Harman, P. (1962). Suppression of experimental autoimune encephalomyelitis by stress. Exp. Biol. Med. 109:294-298.
62. Lindsley, M. D., Thiemann, R., and Rodriguez, M. (1991). Cytotoxic T cells isolated from the central nervous system of mice infected with Theiler's virus. J. Virol. 65:6612-6620.
63. Lipton, H. L. (1975). Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1147-1155.
64. Lipton, H. L., and Dal Canto, M. C. (1976). Theiler's virus-induced demyelination: prevention by immunosuppression. Science 192:62-64.
65. Lipton, H. L., Twaddle, G., and Jelachich, M. L. (1995). The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virusinduced demyelinating disease. J. Virol. 69:2525-2533.
66. Lyman, M. A., Myoung, J., Mohindrum, M., and Kim, B. S. (2004). Quantitative, not qualitative, differences in CD8+ T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice. Eur. J. Immunol. 34:2730-2739.
67. Melvold, R. W., Jokinen, D. M., Knobler, R. L., and Lipton, H. L. (1987). Variations in genetic control of susceptibility to Theiler's virus (TMEV)-induced demyelinating disease. J. Immunol. 138:1429-1433.
68. Mi, W., Belyavskyi, M., Johnson, R. R., Sieve, A. N., Storts, R., Meagher, M. W., and Welsh, C. J. R. (2004). Alterations in chemokine expression in Theiler's virus infection and restraint stress. J. Neuroimmunol. 151:103-115.
69. Mi, W., Young, C. R., Storts, R., Steelman, A., Meagher, M. W., and Welsh, C. J. R. (2006a). Stress alters pathogenecity and facilitates systemic dissemination of Theiler's virus. Microbial Pathogenesis in press.
70. Mi, W., Prentice T. W., Young, C. R., Johnson, R. R., Sieve, A. N., Meagher, M. W., Welsh, C. J. R. (2006). Restraint stress decreases virus-induced pro-inflammatory cytokine expression during acute Theiler's virus infection. (In revision for J. Neuroimmounol.)
71. Miguel, H., Zhang, S. M., Lipworth, L., Olek, M. J., and Ascherio, A. (2001). Multiple sclerosis and age at infection with common viruses. Epidemiology 12:301-306.
72. Miller, S. D., Van Derlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., and Kim, B. S. (1997). Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136.
73. Mohr, D. C., Hart, S. L., Julian, L., Cox, D., and Pelletier, D. (2004). Association between stressful life events and exacerbation in Multiple Sclerosis: a meta analysis. B. M. J. 328(7442):731-735.
74. Monteyne, P., Bihl, F., Levillayer, F., Brahic, M., and Bureau, J. F. (1999). The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J. Immunol. 162:7330-7334.
75. Murray, P. D., Pavelko, K. D., Leibowitz, J., Lin, X., and Rodriguez, M. (1998). CD4 (+) and CD8 (+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 72:7320-7329.
76. Nicholson, S. M., Peterson, J. D., Miller, S. D., Wang, K., Dal Canto, M. C., and Melvold, R. W. (1994) BALB/c substrain difference in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neuroimmunol. 52:19-24.
77. Nisipeanu, P., and Korczyn, A. D. (1993). Psychological stress as risk factor for exacerbations in multiple sclerosis. J. Auton. Nerv. Syst. 26:77-84.
78. Okimura, T., Ogawa, M., and Yamauchi, T. (1986). Stress and immune responses III. Effect of restraint stress on delayed type hypersensitivity (DTH) response, natural killer (NK) activity and phagocytosis in mice. Jpn. J. Pharmacol. 41:229-235.
79. O'Leary, A., Shoor, S., Lorig, K., and Holman, H. R. (1988). A cognitive behavioral treatment for rheumatoid arthritis. Health Psychol. 7:527-544.
80. Oleszak, E. L., Chang, J. R., Friedman, H., Katestos, CD., and Platsoucas, CD. (2004). Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 17:174-207.
81. Paya, C. V., Patick, A. K., Leibson, P. J., and Rodriguez, M. (1989). Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143:95-102.
82. Paya, C. V., Leibson, P. J., Patick, A. K., and Rodriguez, M. (1990). Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor-α. Int. Immunol. 2:909.
83. Peterson, J. D., Waltenbaugh, C, and Miller, S. D. (1992). IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology 75:652-658.
84. Pullen, L. C., Miller, S. D., Dal Canto, M. C., and Kim, B. S. (1993). Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287-2293.
85. Pullen, L. C., Miller, S. D., Dal Canto, M. C., Van der Meide, PH., and Kim, B. S. (1994). Alteration in the level of interferon-γ results in acceleration of Theiler's virusinduced demyelinating disease. J. Neuroimmunol. 55:143-152.
86. Pullen, L. C., Park, S. H., Miller, S. D., Dal Canto, M. C, and Kim, B. S. (1995). Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 155:4497.
87. Radojevic, V., Nicassio, P. M., and Weisman, M. H. (1992). Behavioral intervention with and without family support for rheumatoid arthritis. Behav. Ther. 23:13-30.
88. Rimon, R., and Laakso, R. L. (1985). Life stress and rheumatoid arthritis: A 15-year follow-up study. Psychother. Psychosom. 43:38-43.
89. Rodriguez, M., and David, C. S. (1995). H-2Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1:111-117.
90. Rodriguez, M., and Sriram, S. (1988). Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt2 antibody. J. Immunol. 140:2950-2955.
91. Rodriguez, M., Pavelko, K. D., McKinney, C. W., and Leibowitz, J. L. (1994). Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153:3811-3821.
92. Rodriguez, M., Pavelko, K., and Coffman, R. L. (1995). Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69:7286-7290.
93. Rodriguez, M., Pavelko, K. D., Njenga, M. K., Logan, W. C., and Wettstein, P. J. (1996). The balance between persistent virus infection and immune cells determines demyelination. J. Immunol. 157:5699-5709.
94. Roos, R. P., and Wollmann, R. (1984). DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15:494-499.
95. Rossi, P. C., McAllister, A., Fiette, L., and Brahic, M. (1991). Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell. Immunol. 138:341-348.
96. Rossi, C. P., Delcroix, M., Huitinga, I., McAllister, A., Rooijen, N., Claassen, E., and Brahic, M. (1997). Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-3340.
97. Sato, S., Reiner, S. L., Jensen, M. A., and Roos, R. P. (1997). Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J. Neuroimmunol. 76:213-223.
98. Selmaj, K. W., and Raine, C. S. (1987). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
99. Sheridan, J. F. (1998). Stress-induced modulation of anti-viral immunity. Brain Behav. Immun. 12:1-6.
100. Sheridan, J. F., Feng, N., Bonneau, R. H., and Allen, C. M. (1991). Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J. Neuroimmunol. 31:245-255.
101. Sibley, W. A., Bamford, C. R., and Clark, K. (1985). Clinical viral infections and multiple sclerosis. Lancet 1:1313-1315.
102. Sieve, A. N., Steelman, A. J., Young, C. R., Storts, R., Welsh, T. H., Welsh, C. J. R., and Meagher, M. W. (2004). Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J. Neuroimmunol. 155:103-118.
103. Steelman, A., Mi, W., Alford, E., Young, C. R., Meagher, M. W., and Welsh, C. J. R. (2006). Restraint stress fails to render resistant C57Bl/6 mice susceptible to Theiler's virus-induced demyelination.. (Manuscript in preparation.)
104. Stininssen, P., Raus, J., and Zhang, J. (1997). Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphcytes and new immunotherapeutic strategies. Crit. Rev. Immunol. 17:33-75.
105. Teshima, H., Sogawa, H., Kihara, H., Magata, S., Ago, Y., and Nakagawa, T. (1987). Changes in populations of T-cell subsets due to stress. Ann. N. Y. Acad. Sci. 496:459-466.
106. Theil, D. J., Tsunoda, I., Libbey, J. E., Derfuss, T. J., and Fujinami, R. S. (2000). Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J. Neuroimmunol. 104:22-30.
107. Theiler, M. (1934). Spontaneous encephalomyelitis of mice-a new virus. Science 80:122.
108. Theiler, M., and Gard, S. (1940). Encephalomyelitis of mice. I. Characteristics and pathogenesis. J. Exp. Med. 72:79.
109. Warren, S., Greenhill, S., and Warren, K. G. (1982). Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. J. Chronic Dis. 35:821-831.
110. Welsh, C. J. R., Tonks, P., Nash, A. A., and Blakemore, W. F. (1987). The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 68:1659-1667.
111. Welsh, C. J. R., Blakemore, W. F., Tonks, P., Borrow, P., and Nash, A. A. (1989). Theiler's murine encephalomyelitis virus infection in mice: A persistent viral infection of the central nervous system which induces demyelination. In N. Dimmock (ed.), Immune Responses, Virus Infection and Disease. Oxford: Oxford University Press, pp. 125-147.
112. Welsh, C. J. R., Tonks, P., Borrow, P., and Nash, A. A. (1990). Theiler's virus: An experimental model of virus-induced demyelination. Autoimmunity 6:105-112.
113. Welsh, C. J. R., Sapatino, B., Rosenbaum, B., Smith. R., and Linthicum, D. S. (1993). Correlation between susceptibility to demyelination and interferon gamma induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells. J. Neuroimmunol. 48:91-98.
114. Welsh, C. J. R., Sapatino, B. V., Rosenbaum, B., and Smith, R. (1995). Characteristics of cloned cerebrovascular endothelial cells following infection with Theiler's virus. I. Acute infection. J. Neuroimmunol. 62:119-125.
115. Welsh, C. J. R., Bustamante, L., Nayak, M., Welsh, T. H., Dean, D. D., and Meagher, M. W. (2004). The effects of restraint stress on the neuropathogenesis of Theiler's virus infection II: NK cell function and cytokine levels in acute disease. Brain Behav. Immun. 18:166-174.
116. Welsh, C. J. R., Sieve, A., Johnson, R., Storts, R., Welsh, T. H., and Meagher, M. W. (2006). The effects of restraint stress on the neuropathogenesis of Theiler's virus infection. II. Chronic disease.. (Manuscript in preparation.)
117. Whetten-Goldstein, K., Sloan, F. A., Goldstein, L. B., and Kulas, E. D. (1998). A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult. Scler. 4:419-425.
118. Whitacre, C. G., Cummings, S. O., and Griffin, A. C. (1994). The effects of stress on autoimmune disease. In R. Glaser, and J. K. Kiecolt-Glaser (eds.), Handbook of Human Stress and Immunity. San Diego: Academic Press, pp. 77-100.
119. Yoon, J. W., Austin, M., Onodera, T., and Notkins, A. L. (1979). Virus induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300:113.
120. Zurbriggen, A., and Fujinami, R. S. (1988). Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J. Virol. 62:3589-3596.
121. Zwilling, B. S., Brown, D., Feng, N., Sheridan, J., and Pearl, D. (1993). The effect of adrenalectomy on the restraint stress induced suppression of MHC class II expression by murine peritoneal macrophages. Brain Behav. Immun. 7:29-35.